Mello Investor Presentation
20 April 2023
S & U PLC
("S&U" or "the Company")
Mello Investor Presentation
S&U (LSE: SUS), the motor finance and specialist lender, is pleased to announce that the Company will be presenting at Mello Monday's virtual investor event taking place via Zoom webinar on Monday 24th April 2023 at 5:30pm.
Anthony Coombs (Chairman) will be presenting and taking questions from participants, alongside Graham Coombs, (Deputy Chairman), Graham Wheeler, (Advantage Finance CEO), Ed Ahrens, (Aspen Bridging Managing Director) and Chris Redford, (Group Finance Director).
If you would like to attend, you can register here for a free ticket for the event using code SHR100.
|
Enquiries Anthony Coombs
|
S&U plc |
c/o SEC Newgate
|
|
Financial Public Relations Bob Huxford, Molly Gretton, Harry Handyside |
SEC Newgate |
020 7653 9848 |
|
Broker Adrian Trimmings, Andrew Buchanan, Sam Milford
|
Peel Hunt LLP |
020 7418 8900
|
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 minute ago NCC Group
- 1 minute ago Bluebird Merchant Ventures (DI)
- 1 minute ago Origin Enterprises (CDI)
- 1 minute ago Elixirr International
- 1 minute ago Allergy Therapeutics